Impact of baseline body mass index on the efficacy and safety of tofacitinib in patients with psoriatic arthritis

Objectives This post-hoc analysis explored the impact of body mass index (BMI) on tofacitinib efficacy/safety in patients with active psoriatic arthritis (PsA).Methods Data were pooled from two phase 3 studies (NCT01877668; NCT01882439). Analyses included patients randomised to tofacitinib 5/10 mg...

Full description

Bibliographic Details
Main Authors: Daniela Graham, Christopher Ritchlin, Jon T Giles, Juan J Gomez Reino, Philip Helliwell, Pamela Young, Wael Joseph, Rajiv Mundayat
Format: Article
Language:English
Published: BMJ Publishing Group 2021-04-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/7/1/e001486.full